Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Multiple Myeloma

Cross Cancer Institute, Edmonton, Alberta, Canada

BCCA - Kelowna, Kelowna, British Columbia, Canada

BCCA - Vancouver, Vancouver, British Columbia, Canada

CancerCare Manitoba, Winnipeg, Manitoba, Canada

The Moncton Hospital, Moncton, New Brunswick, Canada

Regional Health Authority B, Zone 2, Saint John, New Brunswick, Canada

Dr. H. Bliss Murphy Cancer Centre, St. John's, Newfoundland and Labrador, Canada

Royal Victoria Regional Health Centre, Barrie, Ontario, Canada

William Osler Health System, Brampton, Ontario, Canada

Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton, Ontario, Canada

Kingston Health Sciences Centre, Kingston, Ontario, Canada

Waterloo Regional Health Network (WRHN), Kitchener, Ontario, Canada

London Health Sciences Centre Research Inc., London, Ontario, Canada

Stronach Regional Health Centre at Southlake, Newmarket, Ontario, Canada

Lakeridge Health Oshawa, Oshawa, Ontario, Canada

Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

Algoma District Cancer Program, Sault Ste. Marie, Ontario, Canada

Niagara Health System, St. Catharines, Ontario, Canada

St. Michael's Hospital, Toronto, Ontario, Canada

St. Joseph's Health Centre, Toronto, Ontario, Canada

Windsor Regional Cancer Centre, Windsor, Ontario, Canada

CIUSSS de l'Est-de-I'lle-de-Montreal, Montreal, Quebec, Canada

The Jewish General Hospital, Montreal, Quebec, Canada

St. Mary's Hospital, Montreal, Quebec, Canada

The Research Institute of the McGill University, Montreal, Quebec, Canada

CHU de Quebec-Hopital l'Enfant-Jesus (HEJ), Québec, Quebec, Canada

Allan Blair Cancer Centre, Regina, Saskatchewan, Canada

Saskatoon Cancer Centre, Saskatoon, Saskatchewan, Canada